


48th Human Genetics Society of Australasia (HGSA) Annual Scientific Meeting
This year’s theme, "Genetic Ecosystems," highlights the critical collaboration between academia, research institutions, healthcare providers, and technology firms to advance genomic medicine in modern healthcare systems. It reflects the interconnectedness of various disciplines working together to unravel the complexities of human genetics and implement ground-breaking innovations in clinical practice.
The Meeting promises an engaging and comprehensive exploration of the latest developments in human genetics and genomics. Topics will span a wide spectrum of issues, including equity in healthcare, ethical dilemmas, and the integration of genomics into everyday medical practice. Key scientific sessions will focus on areas such as genomic newborn screening for early detection of childhood conditions, cutting-edge genetic research on Indigenous populations and rare diseases, as well as the application of functional genomics platforms to better understand the clinical relevance of genetic variants.


AUS-oMICS 2025
Incorporating the 30th Proteomics Symposium, 30th ANZSMS Meeting, Australia and New Zealand Metabolomics Society & 6th Australasian Glycoscience Symposium
The Conference is situated in the heart of sub-tropical Cairns, a charming city with breathtaking views. Attendees can not only access the leading minds in the field but also enjoy the surroundings and the abundant local native wildlife.
The conference will welcome academic and industrial researchers worldwide, along with the next generation of young researchers and students.

Power Up Your Multi-Omic Discoveries I Next Gen Olink® Proteomics
This In-person and Live-stream seminar will feature insights from Dr Samuel Montgomery, The Kids Research Institute Australia, and Dr Benjamin Cooper, AGRF on the power of affinity-based proteomics in clinical and laboratory research.
Dr Montgomery will present findings from both large-scale and targeted proteomics studies on respiratory viral infections and chronic lung diseases, including asthma and cystic fibrosis.
Dr Cooper will highlight Olink’s integrated platforms—Reveal, Target, and Explore HT—and their role in accelerating biomarker discovery and understanding complex biological systems.
Together, the sessions reveal how modern proteomics is reshaping our approach to disease research and fast-tracking clinical break throughs.
We look forward to welcoming you to this seminar. Please register your in-person or online attendance via the links below.

Power Up Your Multi-Omic Discoveries I Next Gen Olink® Proteomics
This in-person and live-streamed seminar highlights the transformative potential of Next-Generation Sequencing (NGS), Olink Proteomics in achieving comprehensive multi-omic insights. By integrating proteomics with genomics and other omics data, NGS enables deeper, more accurate understanding of complex biological systems.

Multi-Omics 2024
Multi-omics, leveraged by cutting-edge technological breakthroughs, are revolutionizing how we understand disease biology. The field of multi-omics has exploded over the last few years with applications spanning cancer, infectious disease and immunology.
Over 3 days, this meeting will deliver forward-thinking perspectives on the latest in multi-omics, including Spatial Biology, Digital Pathology, Artificial-intelligence, and Omics-based deep tissue and liquid biopsy profiling.
The vision of the Multi-omics 2024 meeting is to bring together the critical mass of Multi-omics researchers both nationally, and internationally, with exciting sessions in immuno-oncology, infectious disease and immunology. The meeting will feature experimental design, methodologies, and analytical pipelines including bioinformatics, computational biology and pathology. This will be supported by multiple technology companies, platform launches, technical workshops and real-world datasets.

Sydney International Conference | Advancing Multi-Omics into the Clinic
Sydney International Conference, ‘Advancing Multi-Omics into the Clinic’. Through this two-day meeting, internationally renowned experts in proteomics, genomics, cancer management, biomarker and drug discovery will share their progress towards addressing the challenges and opportunities of multi-omic data integration in cancer management, with a special focus on the role of proteomics in advancing biomarker development and drug discovery.